CellaVision AB (publ) (CLVSF)
OTCMKTS
· Delayed Price · Currency is USD
19.28
-0.63 (-3.16%)
At close: Jan 23, 2025
CellaVision AB Revenue
In the year 2024, CellaVision AB had annual revenue of 723.22M SEK with 6.78% growth. CellaVision AB had revenue of 186.69M in the quarter ending December 31, 2024, a decrease of -6.95%.
Revenue
723.22M SEK
Revenue Growth
+6.78%
P/S Ratio
6.11
Revenue / Employee
3.30M SEK
Employees
219
Market Cap
399.56M USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 723.22M | 45.93M | 6.78% |
| Dec 31, 2023 | 677.29M | 37.95M | 5.94% |
| Dec 31, 2022 | 639.34M | 73.79M | 13.05% |
| Dec 31, 2021 | 565.55M | 94.11M | 19.96% |
| Dec 31, 2020 | 471.44M | 9.67M | 2.09% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |
CellaVision AB News
- 2 months ago - CellaVision AB (CLVSF) Q4 2024 Earnings Call Highlights: Record APAC Sales and Strategic Growth ... - GuruFocus
- 2 months ago - Q4 2024 CellaVision AB Earnings Call Transcript - GuruFocus
- 6 months ago - Q3 2024 CellaVision AB Earnings Call Transcript - GuruFocus
- 4 years ago - 3 Scandinavian Companies With Strong Margin Growth - GuruFocus